Regulator nixes Indian Immunologicals plan for 6-in-1 vaccine over China polio strain
The Central Drugs Standard Control Organization (CDSCO) has rejected Indian Immunologicals Ltd’s request for human trials of a six-in-one vaccine, according to two officials and documents seen by Mint. The regulator worries that an unintended leak of the polio strain could revive the crippling disease, which was banished from the country 14 years ago. Documents…